Search

everythinglearnresearchcommunity

for

Search:↓

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Soy protein with isoflavones reduces wrinkles and improves skin hydration in postmenopausal women.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Trichoscopy helps diagnose frontal fibrosing alopecia, even with unusual patterns.

A postmenopausal woman's excess male hormone symptoms were caused by a rare adrenal gland tissue in her ovary.

Cosmetic products or emotional factors might contribute to Frontal Fibrosing Alopecia, and trichoscopy is useful for diagnosis.

Frontal fibrosing alopecia may be caused by an autoimmune reaction and hormonal imbalance.

High-dose finasteride effectively treats hair loss in postmenopausal women.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

A woman's increased facial hair and hair loss were caused by a rare ovarian tumor, cured by surgery.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.